Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem population pharmacokinetic and machine learning concentration prediction study in pediatric oncology patients
ChiCTR2600131505Phase 4Recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-Sen University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of meropenem in bacterial disease and febrile neutropenia (FN), sponsored by The Seventh Affiliated Hospital, Sun Yat-Sen University. Primary endpoint: Meropenem plasma concentration. Started Feb 2026; status: recruiting.
02
Drugs
meropenem
03
Conditions
bacterial diseasefebrile neutropenia (FN)
Beyond the preview
Go deeper on ChiCTR2600131505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131505.